Literature DB >> 20871264

Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population.

Raja M Flores1, Elyn Riedel, Jessica Scott Donington, William Alago, Ugonna Ihekweazu, Lee Krug, Kenneth Rosenzweig, Prasad S Adusumilli, Michele Carbone, Harvey I Pass.   

Abstract

INTRODUCTION: Surgical intervention rates for mesothelioma patients treated at specialized tertiary hospitals are well more than 42%. Mesothelioma surgical strategies in the community are less well defined. This study evaluates the frequency of use and predictors of cancer-directed surgical intervention in a nontertiary-based population and the predictors for surgical intervention.
METHODS: The Surveillance, Epidemiology, and End Results database was searched from 1990 to 2004. Variables analyzed included age, sex, race, year of diagnosis, region, vital status, stage, surgery, and reasons for no surgery. The association of patient variables on receipt of cancer-directed surgery was evaluated using χ(2) tests and logistic regression. The incidence of mesothelioma was also evaluated over this period of time.
RESULTS: Pathologically proven malignant pleural mesothelioma was identified in 1166 women and 4771 men. The rate of cancer-directed surgery was 22% (n = 1317). Significant predictors of receiving cancer-directed surgery included race, age, and stage (all p < 0.0001). A landmark analysis on the effect of cancer-directed surgery on survival after adjusting for patient and disease characteristics demonstrated a hazard ratio of 0.68 (p < 0.0001). The incidence rate of malignant pleural mesothelioma has remained constant.
CONCLUSIONS: The rate of surgical intervention in the community is lower compared with tertiary referral centers. Age, stage, and race predict the likelihood of receiving cancer-directed surgery. A lower rate of cancer-directed surgery and worse overall outcome were observed in black patients. As part of quality assurance, referral of patients to centers with multidisciplinary programs that include thoracic surgical expertise should be considered.

Entities:  

Mesh:

Year:  2010        PMID: 20871264     DOI: 10.1097/JTO.0b013e3181f1903e

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  28 in total

1.  Racial Disparities in Treatment Patterns and Survival Among Surgically Treated Malignant Pleural Mesothelioma Patients.

Authors:  Naomi Alpert; Maaike van Gerwen; Meredith Steinberg; Nisha Ohri; Raja Flores; Emanuela Taioli
Journal:  J Immigr Minor Health       Date:  2020-12

2.  Update in lung cancer and oncological disorders 2010.

Authors:  Balazs Halmos; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2011-08-01       Impact factor: 21.405

Review 3.  Overview of treatment related complications in malignant pleural mesothelioma.

Authors:  David J Murphy; Ritu R Gill
Journal:  Ann Transl Med       Date:  2017-06

4.  The impact of surgical approach on quality of life for pleural malignant mesothelioma.

Authors:  Rebecca M Schwartz; Alexis Watson; Andrea Wolf; Raja Flores; Emanuela Taioli
Journal:  Ann Transl Med       Date:  2017-06

5.  Role of postoperative radiotherapy in the management of malignant pleural mesothelioma : A propensity score matching of the SEER database.

Authors:  Omar Abdel-Rahman
Journal:  Strahlenther Onkol       Date:  2017-01-02       Impact factor: 3.621

6.  Mesothelioma diagnosis and prognosis, are we moving beyond histology and performance status towards circulating biomarkers?

Authors:  Oluf Dimitri Røe
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

7.  Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients.

Authors:  Elliot L Servais; Christos Colovos; Luis Rodriguez; Adam J Bograd; Jun-ichi Nitadori; Camelia Sima; Valerie W Rusch; Michel Sadelain; Prasad S Adusumilli
Journal:  Clin Cancer Res       Date:  2012-02-27       Impact factor: 12.531

8.  Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma.

Authors:  Chi-Fu Jeffrey Yang; Brandon W Yan; Robert Ryan Meyerhoff; Shakir M Saud; Brian C Gulack; Paul J Speicher; Matthew G Hartwig; Thomas A D'Amico; David H Harpole; Mark F Berry
Journal:  Clin Lung Cancer       Date:  2016-03-17       Impact factor: 4.785

9.  Pleurectomy/decortication versus extrapleural pneumonectomy: a critical choice.

Authors:  Pier Luigi Filosso; Francesco Guerrera; Paolo Olivo Lausi; Roberto Giobbe; Paraskevas Lyberis; Enrico Ruffini; Alberto Oliaro
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

10.  Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database.

Authors:  Maaike Van Gerwen; Naomi Alpert; Andrea Wolf; Nisha Ohri; Erik Lewis; Kenneth E Rosenzweig; Raja Flores; Emanuela Taioli
Journal:  Carcinogenesis       Date:  2019-06-10       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.